Skip to main content
. 2022 Jul 6;2022:6253978. doi: 10.1155/2022/6253978

Figure 7.

Figure 7

The in vitro release profile (n = 3). In the first hour of incubation, the formulation exhibited a slow release rate, and only 6.5 ± 0.25% of the doxorubicin was released after 60 min. However, the release rate increased by increasing the incubation time, and finally, 96.16 ± 1.97% of the drug was released after 48 hours.